Early Access — free while we kick the tires
EdgarHawk

Gray Nancy Ryan

Director

Director
1 filing analyzed · 1 company · Latest 2025-11-12

Companies

Company Buys Sells Direction
LIGAND PHARMACEUTICALS INC LGND 0 4 Net selling

Activity

November 2025
medium
Sell
6,571 shares
$1,350,012
Significance 5/10

Director Gray Nancy Ryan sold 6,571 shares at $205.45 on 2025-11-07 for $1.4M, reducing holdings by 44.8% post-transaction.

Director Gray Nancy Ryan executed 2 separate sales totaling 6,571 shares for $1,350,011.95 at $205.45, reducing her holdings from 14,665 shares to 8,094 shares, a 44.8% reduction. The transaction occurred as LGND stock trades near its 52-week high ($205.45 vs. 52-week high of $209.29), having appreciated 14.3% over 30 days and 33.7% over 90 days. While the company reported strong recent-quarter net income of $117,273,000.00, it was unprofitable on a full-year basis and carries a high P/E of 83.24, reflecting elevated valuation expectations. The significant reduction in director shareholding warrants investor attention regarding management's view of current valuation and capital allocation priorities.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access